期刊
NATURE MEDICINE
卷 14, 期 6, 页码 641-647出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm1778
关键词
-
资金
- NCI NIH HHS [5R01CA112414, R01 CA112414-02, R01 CA112414] Funding Source: Medline
- NIAID NIH HHS [AI058828, P30 AI054999, R01 AI058828, P30 AI054999-03, R01 AI058828-05] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA112414] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058828, P30AI054999] Funding Source: NIH RePORTER
The HIV-1 Vpu protein is required for efficient viral release from human cells. For HIV-2, the envelope (Env) protein replaces the role of Vpu. Both Vpu and HIV-2 Env enhance virus release by counteracting an innate host-cell block within human cells that is absent in African green monkey (AGM) cells. Here we identify calcium-modulating cyclophilin ligand (CAML) as a Vpu-interacting host factor that restricts HIV-1 release. Expression of human CAML (encoded by CAMLG) in AGM cells conferred a strong restriction of virus release that was reversed by Vpu and HIV-2 Env, suggesting that CAML is the mechanistic link between these two viral regulators. Depletion of CAML in human cells eliminated the need for Vpu in enhancing HIV-1 and murine leukemia virus release. These results point to CAML as a Vpu-sensitive host restriction factor that inhibits HIV release from human cells. The ability of CAML to inhibit virus release should illuminate new therapeutic strategies against HIV.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据